Skip to main content
. Author manuscript; available in PMC: 2021 Jul 12.
Published in final edited form as: Support Care Cancer. 2019 Dec 6;28(8):3679–3689. doi: 10.1007/s00520-019-05207-z

Table 2.

Median motor ability, function, HRQOL, and symptom severity at baseline and 6 months and statistical change over time

Measures Median
Wilcoxon signed-rank test
Na Baseline 6 months p value
Motor
 JTHFT 13 45.2 49.4 0.685
 GPT 13 101.5 106.6 0.735
 Grip strength (lbs) Pinch strength (lbs) 12 50.8 54.8 0.230
  Tip-to-tip 13 10.0 9.0 0.679
  Palmar 13 14.0 16.0 0.401
  Key 13 15.0 17.0 0.331
 2MWT (ft) 11 610.2 607.0 0.413
Functional
 AMPS
  ADL motor skill 13 1.7 1.5 0.340
  ADL process skill 13 1.9 1.7 0.505
 DASH 12 34.2 22.9 0.733
 HAP
  AAS 12 69.0 69.5 0.247
  MAS 12 78.0 79.5 0.552
 MAM-36 12 66.0 69.0 0.223
Quality of life
 SF-36
  PCS 12 35.3 38.6 0.910
  MCS 12 51.3 52.2 0.677
Symptom severity
 Provider Global Rating 13 6.0 6.0 0.551
 Lee Symptom Scale 13 25.0 22.5 0.102

JTHFT, GPT, and pinch strength scores refer to performance with the dominant hand. Higher scores on the DASH, JTHFT, and GPT indicate poorer performance. Higher scores on the PGR and Lee Symptom Scale indicate greater symptom severity. On all other measures, higher scores indicate improved performance

a

Number of patients with data on each measure at both baseline and 6 months. Data for these individuals were used to calculate median scores at each time point. DASH, HAP, MAM-36, and SF-36 scores were missing from one patient due to young age (< 18 years old). For the 2MWT and grip strength, missing data were not collected